Biomarker Strategies for Optimizing Checkpoint Immunotherapy Treatment

Explore an overview of current biomarker strategies for guiding the use of combination checkpoint immunotherapies in blood cancers

[wpbb post:title]
Dr. Naval Daver, Associate Professor, Department of Leukemia, MD Anderson Cancer Center
  • Review advanced immune-based approaches in acute myeloid leukemia that combine chemotherapy with checkpoint therapy

  • Explore relevant biomarker strategies associated with these approaches

  • See how single-cell cytokine analysis system and PSI demonstrate that specific cytokine potency contributors correlate with overall survival